New Weight-Loss shot shows promise in Mid-Stage trial

NCT ID NCT07020884

Completed Disease control Sponsor: Beijing QL Biopharmaceutical Co.,Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental injection called ZT002 in 303 adults who were overweight or obese. Participants received either the drug or a placebo for 24 weeks. The main goal was to see how much weight they lost and whether they achieved 5%, 10%, or 15% weight loss. The trial is now complete, and results will help determine if ZT002 is safe and effective for weight management.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVERWEIGHT OR OBESITY

Contacts and locations

Locations

Affiliated Hospital of Jiangsu University

Zhenjiang, Jiangsu, 212000, China
Central Hospital Affiliated to Shandong First Medical University

Jinan, Shandong, 250000, China
First Hospital of Qinhuangdao

Qinhuangdao, Hebei, 066000, China
Genertec Liaoyou Gem Flower Hospital

Panjin, Liaoning, 124000, China
Handan First Hospital

Handan, Hebei, 056002, China
Hebei Petro China Cental Hospital

Langfang, Hebei, 065000, China
Luoyang Third People's Hospital

Luoyang, Henan, 471002, China
Nanjing Jiangning Hospital

Nanjing, Jiangsu, 210000, China
Peking University First Hospital

Beijing, 100044, China
Peking University People's Hospital

Beijing, 100044, China
The First Affiliated Hospital of Henan University of Science & Technology

Luoyang, Henan, 471000, China
The First Affiliated of Nanyang Medical College

Nanyang, Henan, 473000, China
The Fourth Affiliated Hospital Harbin Medical University

Harbin, Heilongjiang, 150001, China
Tonghua Central Hospital

Tonghua, Jilin, 134000, China
Xi'an Daxing Hospital

Xi’an, Shanxi, 710000, China
Zibo Municipal Hospital

Zibo, Shandong, 255400, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.